Pharmaceutical business predicted slow next year.

Published: 2001-12-27 06:58:00

Updated: 2001-12-27 06:58:00

Many economic experts as well as general analysts forecasted the pharmaceutical business next year slightly slower than this year, viewing that the business this year enjoyed far favorable than other industry and the government restrictive policy of pricing slash will be imposed over the medical ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK